In the first of a series, columnist Joe MacDonald reflects on the birth of his oldest son, who hadn't yet been diagnosed with hemophilia.

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

A caregiver needs respite from the duties of watching over a chronically ill patient, columnist Cazandra Campos-MacDonald writes.

Successful immune tolerance induction (ITI) in hemophilia A patients with inhibitors led to lower treatment costs, a study ...

Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...

Early diagnosis allows for timely preventive treatment and reduces the need for intensive factor replacement therapy in ...

Columnist G Shellye Horowitz chats with four women about their struggles to obtain a von Willebrand disease diagnosis.

Columnist Alliah Czarielle says her husband, Jared, adapts to whatever hemophilia and epilepsy throw his way. Being present is the core.

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.

Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged period of time — that ...

Hemophilia A is a rare genetic disorder that affects the blood’s ability to clot properly. It is the most common form of hemophilia, responsible for 80% of all cases. The condition is caused by a ...